Ignite Creation Date:
2024-05-06 @ 2:08 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04225429
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-03-22
First Post:
2020-01-08
Brief Title:
Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
Sponsor:
Epizyme Inc
Organization:
Ipsen
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2020-01-08
First Submit QC Date:
January 8 2020
Study First Post Date:
2020-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-03-22
Last Update Post Date Type:
ACTUAL